These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26362576)

  • 1. QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis.
    Sobue Y; Harada M; Koshikawa M; Ichikawa T; Yamamoto M; Okuda K; Kato Y; Sarai M; Watanabe E; Ozaki Y
    Heart Rhythm; 2015 Dec; 12(12):2499-507. PubMed ID: 26362576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the ECG based Selvester scoring method to estimate myocardial scar burden and predict clinical outcome in patients with left bundle branch block, with comparison to late gadolinium enhancement CMR imaging.
    Chaudhry U; Platonov PG; Jablonowski R; Couderc JP; Engblom H; Xia X; Wieslander B; Atwater BD; Strauss DG; Van der Pals J; Ugander M; Carlsson M; Borgquist R
    Ann Noninvasive Electrocardiol; 2017 Sep; 22(5):. PubMed ID: 28248005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
    Watanabe E; Kimura F; Nakajima T; Hiroe M; Kasai Y; Nagata M; Kawana M; Hagiwara N
    J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation.
    Nagai T; Kohsaka S; Okuda S; Anzai T; Asano K; Fukuda K
    Chest; 2014 Oct; 146(4):1064-1072. PubMed ID: 24853830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of 12-lead electrocardiogram Selvester QRS scoring criteria to diagnose myocardial scar in patients with hypertrophic cardiomyopathy.
    Chen S; Wang X; Huang L; Chen Y; Zhang Q
    Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12762. PubMed ID: 32378804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.
    Smedema JP; Snoep G; van Kroonenburgh MP; van Geuns RJ; Dassen WR; Gorgels AP; Crijns HJ
    J Am Coll Cardiol; 2005 May; 45(10):1683-90. PubMed ID: 15893188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias.
    Cain MA; Metzl MD; Patel AR; Addetia K; Spencer KT; Sweiss NJ; Beshai JF
    Am J Cardiol; 2014 May; 113(9):1556-60. PubMed ID: 24731652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can QRS scoring predict left ventricular scar and clinical outcomes?
    Rosengarten JA; Scott PA; Chiu OK; Shambrook JS; Curzen NP; Morgan JM
    Europace; 2013 Jul; 15(7):1034-41. PubMed ID: 23493411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis.
    Strauss DG; Selvester RH; Lima JA; Arheden H; Miller JM; Gerstenblith G; Marbán E; Weiss RG; Tomaselli GF; Wagner GS; Wu KC
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):327-36. PubMed ID: 19808427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.
    Matsumoto K; Ehara S; Sakaguchi M; Otsuka K; Hasegawa T; Shimada K; Yoshiyama M
    Osaka City Med J; 2015 Jun; 61(1):9-17. PubMed ID: 26434101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
    Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
    Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Selvester QRS score as a predictor of cardiac events in nonischemic dilated cardiomyopathy.
    Hiraiwa H; Okumura T; Sawamura A; Sugiura Y; Kondo T; Watanabe N; Aoki S; Ichii T; Kitagawa K; Kano N; Fukaya K; Furusawa K; Morimoto R; Takeshita K; Bando YK; Murohara T
    J Cardiol; 2018 Mar; 71(3):284-290. PubMed ID: 29066100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis.
    Agoston-Coldea L; Kouaho S; Sacre K; Dossier A; Escoubet B; Chillon S; Laissy JP; Rouzet F; Kutty S; Extramiana F; Leenhardt A; Borie R; Crestani B; Ou P
    Int J Cardiol; 2016 Nov; 222():950-956. PubMed ID: 27526366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.
    Murtagh G; Laffin LJ; Beshai JF; Maffessanti F; Bonham CA; Patel AV; Yu Z; Addetia K; Mor-Avi V; Moss JD; Hogarth DK; Sweiss NJ; Lang RM; Patel AR
    Circ Cardiovasc Imaging; 2016 Jan; 9(1):e003738. PubMed ID: 26763280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Cardiac Magnetic Resonance Scar Features by 12-Lead ECG, in Patients with Preserved Ejection Fraction.
    Mewton N; Strauss DG; Rizzi P; Verrier RL; Liu CY; Tereshchenko LG; Nearing B; Volpe GJ; Marchlinski FE; Moxley J; Killian T; Wu KC; Spooner P; Lima JA
    Ann Noninvasive Electrocardiol; 2016 Jan; 21(1):49-59. PubMed ID: 26806840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia.
    Sakamoto N; Sato N; Oikawa K; Karim Talib A; Sugiyama E; Minoshima A; Tanabe Y; Takeuchi T; Akasaka K; Saijo Y; Kawamura Y; Hasebe N
    Heart Rhythm; 2015 Aug; 12(8):1747-55. PubMed ID: 25916568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional abnormalities on cardiac magnetic resonance imaging and arrhythmic events in patients with cardiac sarcoidosis.
    Okada DR; Xie E; Assis F; Smith J; Derakhshan A; Gowani Z; Ambale-Venkatesh B; Gilotra NA; Zimmerman SL; Berger RD; Calkins H; Lima JAC; Tandri H; Chrispin J
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1967-1976. PubMed ID: 31328324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial dispersion analysis of LGE-CMR for prediction of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Aronis KN; Okada DR; Xie E; Daimee UA; Prakosa A; Gilotra NA; Wu KC; Trayanova N; Chrispin J
    Pacing Clin Electrophysiol; 2021 Dec; 44(12):2067-2074. PubMed ID: 34766627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.